<DOC>
	<DOCNO>NCT01887275</DOCNO>
	<brief_summary>The purpose study investigate efficacy safety medical ozone treatment chronic hepatitis B patient .</brief_summary>
	<brief_title>A Control Study Evaluate The Efficacy And Safety Ozone-therapy Chronic Hepatitis B</brief_title>
	<detailed_description>Total 439 patient chronic hepatitis B divide accord patient ' intention two arm . 173 patient arm I treat medical ozone therapy humares make Germany least 12 weeks.266 patient arm II treat conventional interferon-α least 24 weeks.Patients group followed-up 24 weeks.Virology response , biochemistry response hepatitis B viral serological response study 12 week treatment , end treatment 24 week follow-up .</detailed_description>
	<mesh_term>Hepatitis</mesh_term>
	<mesh_term>Hepatitis A</mesh_term>
	<mesh_term>Hepatitis , Chronic</mesh_term>
	<mesh_term>Hepatitis B</mesh_term>
	<mesh_term>Hepatitis B , Chronic</mesh_term>
	<mesh_term>Interferons</mesh_term>
	<criteria>Male female； HBsAg positive 6 months； ALT 2×ULN , TBIL le 80 µmol/L . Patient history hemorrhagic hemolysis disease ; Patient history clinical signs/symptoms hepatic decompensation serious metabolic hepatic disease ; Patient coinfected HIV HCV ; Patient treat antivirus drug like interferon nucleoside analogue recent 6 month ; Patient treat immunosuppressive agent long time , include patient history organ transplantation ; Pregnancy ; Current alcohol drug abuse ; Difficulty draw blood vein ; Patient history carcinoma , find suggestive possible hepatocellular carcinoma ( HCC ) , AFP 100ng/ml ; Patient history severe physical disease cardiovascular , kidney event , hyperthyroidism serious electrolyte disturbance ; Patient enrol clinical trial .</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>October 2012</verification_date>
	<keyword>Chronic hepatitis B</keyword>
	<keyword>Medical Ozone</keyword>
	<keyword>Interferon-α</keyword>
	<keyword>Efficacy</keyword>
</DOC>